BioStock: PHI on the alliance for cell-based biomanufacturing

November 23, 2022
Language flag

Phase Holographic Imaging, PHI, recently created a US-based alliance for advancing cell-based biomanufacturing with Wake Forest Institute for Regenerative Medicine, BioSpherix, QIAGEN and global analytics company SAS. At their new offices at the Regenerative Medicine Hub in North Carolina, PHI will develop its non-invasive technology for cell quality control for use in this emerging field of modern medicine.

Kersti Alm, Chief Scientific Officer at PHI, visited BioStock’s studio to talk about the alliance and PHI’s pivotal role in the collaboration.

Watch the interview with Kersti Alm on biostock.se

Latest News

Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 2 December 2024

Phase Holographic Imaging PHI AB (publ), 556542-7811 (the “Company”) will hold an Extraordinary General Meeting on 2 December 2024 at 15.00 CET at the Company’s premises, Skiffervägen 48 in Lund.

PHI resolves on a fully secured rights issue of shares of approximately SEK 64.3 million

The Board of Directors of Phase Holographic Imaging PHI AB has today resolved on a rights issue of shares, with preferential rights for the Company’s existing shareholders, of approximately SEK 64.3 million before deduction of issue related costs, subject to approval by the extraordinary general meeting to be held on 2 December 2024. The purpose of the Rights Issue is to fund a strategic development plan and to strengthen the Company’s capital structure by repayment/off-setting of outstanding loans.

Adopting the final Annual Report

PHI intends to convene a general meeting to adopt the annual report for the fiscal year 2023/2024 and to amend resolutions regarding election of board members and the number of board members.
See All News